Diabetic Medicine SCIE

国际简称：DIABETIC MED 参考译名：糖尿病医学

主要研究方向：医学-内分泌学与代谢非预警期刊审稿周期：一般,3-6周

《糖尿病医学》(Diabetic Medicine)是一本由Wiley-Blackwell Publishing Ltd出版的以医学-内分泌学与代谢为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q2 JCR分区
191 年发文量
3.2 IF影响因子
未开放 是否OA
132 H-index
1984 创刊年份
Monthly 出版周期
English 出版语言

Diabetic Medicine, the official journal of Diabetes UK, is published monthly simultaneously, in print and online editions.

The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans. Categories of publication include research articles, reviews, editorials, commentaries, and correspondence. All material is peer-reviewed.

We aim to disseminate knowledge about diabetes research with the goal of improving the management of people with diabetes. The journal therefore seeks to provide a forum for the exchange of ideas between clinicians and researchers worldwide. Topics covered are of importance to all healthcare professionals working with people with diabetes, whether in primary care or specialist services.

Surplus generated from the sale of Diabetic Medicine is used by Diabetes UK to know diabetes better and fight diabetes more effectively on behalf of all people affected by and at risk of diabetes as well as their families and carers.”

[ 查看全部 ]

投稿咨询加急咨询

Diabetic Medicine期刊信息

ISSN：0742-3071
出版语言：English
是否OA：未开放
E-ISSN：1464-5491
出版地区：ENGLAND
是否预警：否
出版商：Wiley-Blackwell Publishing Ltd
出版周期：Monthly
创刊时间：1984
开源占比：0.2925
Gold OA文章占比：43.08%
OA被引用占比：0.2633...
出版国人文章占比：0.01
出版撤稿占比：0
研究类文章占比：79.58%

Diabetic Medicine CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

7.2

1.303

1.219

学科类别	分区	排名	百分位
大类：Medicine 小类：Internal Medicine	Q1	33 / 167	80%
大类：Medicine 小类：Endocrinology, Diabetes and Metabolism	Q2	64 / 244	73%
大类：Medicine 小类：Endocrinology	Q2	43 / 128	66%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Diabetic Medicine中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	3区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	3区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	3区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	3区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	3区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢	3区

Diabetic Medicine JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：ENDOCRINOLOGY & METABOLISM	SCIE	Q2	81 / 186	56.7%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ENDOCRINOLOGY & METABOLISM	SCIE	Q2	87 / 186	53.49%

Diabetic Medicine历年数据统计

影响因子

中科院分区

Diabetic Medicine中国学者发文选摘

1、MicroRNA-7a-5p ameliorates diabetic peripheral neuropathy by regulating VDAC1/JNK/c-JUN pathway
Author: Jiao, Yang; Zhang, Yue-Hua; Wang, Chun-Yan; Yu, Yang; Li, Yi-Ze; Cui, Wei; Li, Qing; Yu, Yong-Hao

Journal: DIABETIC MEDICINE. 2023; Vol. 40, Issue 1, pp. -. DOI: 10.1111/dme.14890
2、Prevalence and risk factors of cognitive frailty in community-dwelling older adults with diabetes: A systematic review and meta-analysis
Author: Lyu, Qiong; Guan, Chi-Xun; Kong, Ling-Na; Zhu, Jia-Lu

Journal: DIABETIC MEDICINE. 2023; Vol. 40, Issue 1, pp. -. DOI: 10.1111/dme.14935
3、Lysine demethylase KDM5B down-regulates SIRT3-mediated mitochondrial glucose and lipid metabolism in diabetic neuropathy
Author: Jiao, Yang; Li, Yi-Ze; Zhang, Yue-Hua; Cui, Wei; Li, Qing; Xie, Ke-Liang; Yu, Yang; Yu, Yong-Hao

Journal: DIABETIC MEDICINE. 2023; Vol. 40, Issue 1, pp. -. DOI: 10.1111/dme.14964
4、The vicious circle of UHRF1 down-regulation and KEAP1/NRF2/HO-1 pathway impairment promotes oxidative stress-induced endothelial cell apoptosis in diabetes
Author: Guo, Zi; Wan, Xinxing; Luo, Yufang; Liang, Fang; Jiang, Siwei; Yuan, Xiuhong; Mo, Zhaohui

Journal: DIABETIC MEDICINE. 2023; Vol. 40, Issue 4, pp. -. DOI: 10.1111/dme.15026
5、Ascorbic acid protects retinal pigment epithelial cells from high glucose by inhibiting the NF-kappa B signal pathway through MALAT1/IGF2BP3 axis
Author: Tian, Yanming; Cheng, Wubo; Wang, Haiyan; Zeng, Chengcheng; Chen, Xueyi

Journal: DIABETIC MEDICINE. 2023; Vol. 40, Issue 5, pp. -. DOI: 10.1111/dme.15050
6、Applications of continuous glucose monitoring across settings and populations: Report from the 23rd Hong Kong diabetes and cardiovascular risk factors-East meets west symposium
Author: Oliver, Nick; Chow, Elaine; Luk, Andrea O. Y.; Murphy, Helen R.

Journal: DIABETIC MEDICINE. 2023; Vol. 40, Issue 5, pp. -. DOI: 10.1111/dme.15038
7、Identification of signalling downstream of the transcription factor forkhead box protein M1 that protects against endoplasmic reticulum stress in a diabetic foot ulcer model
Author: Peng, Weixia; Zhu, Ting; Xiang, Guangda; Ding, Ting; Zhao, Jun; Xiong, Dan; Zhong, Yaqin; Zhang, Youqi

Journal: DIABETIC MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.1111/dme.15051
8、The interface targeting hnRNPA2B1 regulates the repression of transthyretin against human retinal microvascular endothelial cells in high-glucose environment
Author: Tian, Yikun; Ye, Lu; Shao, Jun; Xin, Yu

Journal: DIABETIC MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.1111/dme.15125